Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Apr 30;9(2):75-81.
doi: 10.5826/dpc.0902a01. eCollection 2019 Apr.

Nonsurgical Options for the Treatment of Basal Cell Carcinoma

Affiliations

Nonsurgical Options for the Treatment of Basal Cell Carcinoma

John Paoli et al. Dermatol Pract Concept. .

Abstract

Objectives: The aim of this review article is to summarize the effectiveness, potential adverse events, and indications of the main nonsurgical treatment alternatives for basal cell carcinoma.

Methods: An extensive literature review was carried out. The most relevant articles were discussed and selected by the authors in order to provide a brief but evidence-based overview of the most common nonsurgical methods used for treating basal cell carcinoma.

Results: Although surgery and Mohs micrographic surgery are often considered the optimal treatment options for basal cell carcinoma, these tumors can also be treated successfully with destructive techniques (eg, curettage alone, cryosurgery, or electrodesiccation), photodynamic therapy, topical drugs (eg, 5-fluorouracil, imiquimod, or ingenol mebutate), radiotherapy, or hedgehog pathway inhibitors. When choosing between these alternatives, physicians must take into consideration the tumor's size, location, and histopathological subtype. Special care should be taken when treating recurrent tumors. Furthermore, physician experience is of great importance when using destructive techniques. Finally, patient preference, potential adverse events, and cosmetic outcome should also be considered.

Conclusions: Dermatologists and physicians treating basal cell carcinoma should have knowledge of and experience with the large arsenal of therapeutic alternatives available for the successful, safe, and individualized management of patients with basal cell carcinoma.

Keywords: basal cell carcinoma; destructive therapy; hedgehog inhibitors; radiotherapy; topical drugs.

PubMed Disclaimer

Conflict of interest statement

Competing interests: The authors have no conflicts of interest to disclose.

References

    1. Trakatelli M, Morton C, Nagore E, et al. Update of the European guidelines for basal cell carcinoma management. Eur J Dermatol. 2014;24(3):312–329. - PubMed
    1. El Ghissassi F, Baan R, Straif K, et al. A review of human carcinogens, part D: radiation. Lancet Oncol. 2009;10(8):751–752. - PubMed
    1. Kasper M, Jaks V, Hohl D, Toftgard R. Basal cell carcinoma: molecular biology and potential new therapies. J Clin Invest. 2012;122(2):455–463. - PMC - PubMed
    1. LeBoit PE. Pathology and Genetics of Skin Tumours. IARC Press; 2006.
    1. Weinstock MA. Epidemiology of nonmelanoma skin cancer: clinical issues, definitions, and classification. J Invest Dermatol. 1994;102(6):4S–5S. - PubMed

LinkOut - more resources